CVS
CVS Health Corporation
Price performance
Sep 18, 2026About
Company activity
34 events| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 08/17 | CVS | 8-K | CVS Health Appoints Teresa Heitsenrether to Board | — | — | — |
| 08/05 | CVS | 8-K | CVS Health Reports Strong Q2 2026 Results and Raises Full-Year Guidance | — | — | — |
| 05/18 | CVS | 8-K | CVS Health Approves New 2026 Incentive Compensation Plan | — | — | — |
| 05/06 | CVS | 8-K | CVS Health Reports Strong Q1 2026 Results and Raises Full-Year Guidance | — | — | — |
| 03/19 | CVS | 8-K | CVS Health Appoints New Independent Director | — | — | — |
| 02/10 | CVS | 8-K | CVS Health Reports Q4 and Full-Year 2025 Financial Results with Revenue Increase and Adjusted EPS Decline | — | — | — |
| 12/09/25 | CVS | 8-K | CVS Health Updates Financial Guidance and Announces Strategy at 2025 Investor Day | — | — | — |
| 11/20/25 | CVS | 8-K | CVS Health Appoints J. David Joyner as Chair of the Board | — | — | — |
| 10/29/25 | CVS | 8-K | CVS Health Reports Third Quarter 2025 Results with Adjusted EPS Beat and Updated Guidance | — | — | — |
| 09/22/25 | CVS | 8-K | Omnicare Initiates Chapter 11 Bankruptcy to Resolve Litigation and Financial Issues | — | — | — |
| 08/15/25 | CVS | 8-K | CVS Health Announces Debt Issuance | — | — | — |
| 07/31/25 | CVS | 8-K | CVS Health reports Q2 2025 results and updates guidance | — | — | — |
| 05/20/25 | CVS | 8-K | CVS Health Corporation Announces Voting Results from Annual Meeting | — | — | — |
| 05/01/25 | CVS | 8-K | CVS Health Reports Q1 2025 Results and Updates Guidance | — | — | — |
| 04/08/25 | CVS | 8-K | CVS Health Announces CFO Transition and New CMO Appointment | — | — | — |
| 02/12/25 | CVS | 8-K | CVS Health Reports Lower Q4 and Full-Year 2024 Earnings Due to Health Care Benefits Segment Performance | — | — | — |
| 12/17/24 | CVS | 8-K | CVS Health Announces Early Tender Results and Election of Early Settlement for Cash Tender Offer | — | — | — |
| 12/10/24 | CVS | 8-K | CVS Health Corporation Issues Junior Subordinated Notes | — | — | — |
| 12/09/24 | CVS | 8-K | CVS Health Announces Completion of Tender Offer for Senior Notes | — | — | — |
| 12/06/24 | CVS | 8-K | CVS Health Announces Pricing for Tender Offer of 2025 Senior Notes | — | — | — |
| 12/05/24 | CVS | 8-K | CVS Health Announces Issuance of $3 Billion in Junior Subordinated Notes | — | — | — |
| 12/02/24 | CVS | 8-K | CVS Health Initiates Tender Offers for Certain Notes | — | — | — |
| 11/18/24 | CVS | 8-K | CVS Health Announces New Board Members and Confidentiality Agreement with Glenview Capital | — | — | — |
| 11/06/24 | CVS | 8-K | CVS Health Announces Key Leadership Appointments | — | — | — |
| 11/06/24 | CVS | 8-K | CVS Health Reports Lower Earnings in Q3 2024 | — | — | — |
| 10/18/24 | CVS | 8-K | CVS Health Appoints New CEO and Provides Preliminary Q3 2024 Guidance | — | — | — |
| 08/07/24 | CVS | 8-K | CVS Health Reports Q2 2024 Results and Revises Guidance | — | — | — |
| 05/22/24 | CVS | 8-K | CVS Health 2024 Annual Meeting: Stockholder Approvals and Incentive Plan Amendments | — | — | — |
| 05/09/24 | CVS | 8-K | CVS Health Corporation Announces Issuance of Senior Notes | — | — | — |
| 05/08/24 | CVS | 8-K | CVS Health Announces $5 Billion Senior Notes Offering | — | — | — |
| 05/01/24 | CVS | 8-K | CVS Health Revises 2024 Guidance and Reports Q1 2024 Results | — | — | — |
| 03/05/24 | CVS | 8-K | CVS Health Reaffirms 2024 Financial Guidance and Business Updates | — | — | — |
| 02/07/24 | CVS | 8-K | CVS Health Reports 2023 Annual Results | — | — | — |
| 01/05/24 | CVS | 8-K | CVS Health Announces New CFO and Health Care Delivery President, Reaffirms Guidance | — | — | — |
CVS filing record
CVS Health Corporation (CVS): 34 8-K filings summarized, the most recent on Aug 17, 2026.
What the 8-K filings said
- Aug 17, 2026 · medium impact
On August 13, 2026, Larry Robbins resigned from the CVS Health Board, effective immediately. On August 17, 2026, the Board appointed Teresa Heitsenrether, Executive Vice President and Chief Data & Analytics Officer of JPMorgan Chase, to the Board, effective November 18, 2026. Heitsenrether brings nearly forty years of…
CVS Health Appoints Teresa Heitsenrether to Board - Aug 5, 2026 · high impact
CVS Health Corporation announced strong second-quarter 2026 results, with total revenues increasing by 7.3% to $106.1 billion. The company reported GAAP diluted EPS of $2.31 and Adjusted EPS of $2.58. CVS Health also raised its full-year 2026 guidance, with GAAP diluted EPS guidance now ranging from $6.84 to $7.04 and…
CVS Health Reports Strong Q2 2026 Results and Raises Full-Year Guidance - May 18, 2026 · medium impact
On May 14, 2026, CVS Health Corporation held its Annual Meeting of Stockholders where the company's stockholders approved the 2026 Incentive Compensation Plan (ICP), which replaces the expiring 2017 ICP. The 2026 ICP applies to awards granted after May 14, 2026. Additionally, the meeting saw the election of 13…
CVS Health Approves New 2026 Incentive Compensation Plan - May 6, 2026 · high impact
CVS Health Corporation announced strong first quarter 2026 results with total revenues increasing to $100.4 billion, up 6.2% year-over-year. GAAP diluted EPS was $2.30, and Adjusted EPS was $2.57. The company raised its full-year 2026 guidance, with GAAP diluted EPS now expected to be between $6.24 and $6.44, Adjusted…
CVS Health Reports Strong Q1 2026 Results and Raises Full-Year Guidance - Mar 19, 2026 · high impact
On March 18, 2026, CVS Health Corporation announced the election of John E. Gallina to its Board of Directors, effective March 19, 2026. Mr. Gallina, a former CFO of Elevance Health, Inc., brings nearly 30 years of finance and audit experience to the Board. He has been appointed to the Audit Committee and designated…
CVS Health Appoints New Independent Director
SEC filings in the last five years
- 79 Form 8-K
- 13 Form 10-Q
- 5 Form 10-K